Loading...

UCSF Coronavirus Response: UCSF is partnering with public agencies to address the rapidly evolving outbreak and protect our communities. The UCSF COVID-19 Resources Website provides guidance and information for our patients, faculty, staff, trainees and learners.

Frederike Cosima Oertel, PhD

Title(s)Postdoctoral Scholar, Neurology
SchoolSchool of Medicine
vCardDownload vCard

    Collapse Biography 
    Collapse Education and Training
    Charité-Universitätsmedizin Berlin, Berlin, GermanyMD07/2019Medicine
    Charité-Universitätsmedizin Berlin, Berlin, GermanyMD/PhDpendingClinical Neuroimmunology
    Collapse Awards and Honors
    German National Academic Foundation 2012  - 2019Scholarship
    ECTRIMS2016  - 2019Travel Grants (annual)
    Berlin Institute of Health (BIH)2016M.D. Student Research Scholarship
    Berlin Institute of Health (BIH)2016Mobility and Innovation Fund
    German Association for Audiology (“DGA”) 2017Publication Award
    Research Day Multiple Sclerosis 2019, Berlin2019Poster Prize

    Collapse Overview 
    Collapse Overview
    Frederike Oertel completed her M.D. at the Charité-Universitätsmedizin Berlin, Germany, and submitted her M.D./Ph.D., for which she was associated with the Clinical Neuroimmunology Department of the Cluster of Excellence NeuroCure at Charité-Universitätsmedizin Berlin. Frederike Oertel subsequently decided to focus her career on translational MS research and joined Dr. Ari Green's Lab at UCSF as a Postdoctoral Research Scholar in October 2019. Her current research project is focused on visual electrophysiologic alterations in the afferent visual pathway as metrics for the regenerative potential of remyelination in MS.

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. Juenger V, Cooper G, Chien C, Chikermane M, Oertel FC, Zimmermann H, Ruprecht K, Jarius S, Siebert N, Kuchling J, Papadopoulou A, Asseyer S, Bellmann-Strobl J, Paul F, Brandt AU, Scheel M. Optic chiasm measurements may be useful markers of anterior optic pathway degeneration in neuromyelitis optica spectrum disorders. Eur Radiol. 2020 Apr 26. PMID: 32335748.
      View in: PubMed
    2. Zimmermann HG, Oertel FC. Understanding neurodegenerative changes of the afferent visual pathway in MS. Neurol Neuroimmunol Neuroinflamm. 2020 Mar 05; 7(2). PMID: 32229640.
      View in: PubMed
    3. Oertel FC, Outteryck O, Knier B, Zimmermann H, Borisow N, Bellmann-Strobl J, Blaschek A, Jarius S, Reindl M, Ruprecht K, Meinl E, Hohlfeld R, Paul F, Brandt AU, Kümpfel T, Havla J. Optical coherence tomography in myelin-oligodendrocyte-glycoprotein antibody-seropositive patients: a longitudinal study. J Neuroinflammation. 2019 Jul 25; 16(1):154. PMID: 31345223.
      View in: PubMed
    4. Gkaniatsou T, Papadopoulou A, Paul F, Brandt AU, Oertel FC. Frequency of autoimmune disorders and autoantibodies in European patients with neuromyelitis optica spectrum disorders. Acta Neurol Belg. 2020 Feb; 120(1):223-225. PMID: 31264181.
      View in: PubMed
    5. Oertel FC, Schließeit J, Brandt AU, Paul F. Cognitive Impairment in Neuromyelitis Optica Spectrum Disorders: A Review of Clinical and Neuroradiological Features. Front Neurol. 2019; 10:608. PMID: 31258505.
      View in: PubMed
    6. Papadopoulou A, Oertel FC, Gaetano L, Kuchling J, Zimmermann H, Chien C, Siebert N, Asseyer S, Bellmann-Strobl J, Ruprecht K, Chakravarty MM, Scheel M, Magon S, Wuerfel J, Paul F, Brandt AU. Attack-related damage of thalamic nuclei in neuromyelitis optica spectrum disorders. J Neurol Neurosurg Psychiatry. 2019 Oct; 90(10):1156-1164. PMID: 31127016.
      View in: PubMed
    7. Oertel FC, Zimmermann HG, Brandt AU, Paul F. Novel uses of retinal imaging with optical coherence tomography in multiple sclerosis. Expert Rev Neurother. 2019 Jan; 19(1):31-43. PMID: 30587061.
      View in: PubMed
    8. Papadopoulou A, Oertel FC, Zimmermann H, Zeitz O, Brandt AU, Paul F. [Optical Coherence Tomography in Disorders of the Central Nervous System]. Klin Monbl Augenheilkd. 2018 Nov; 235(11):1242-1258. PMID: 30458564.
      View in: PubMed
    9. Oertel FC, Havla J, Roca-Fernández A, Lizak N, Zimmermann H, Motamedi S, Borisow N, White OB, Bellmann-Strobl J, Albrecht P, Ruprecht K, Jarius S, Palace J, Leite MI, Kuempfel T, Paul F, Brandt AU. Retinal ganglion cell loss in neuromyelitis optica: a longitudinal study. J Neurol Neurosurg Psychiatry. 2018 12; 89(12):1259-1265. PMID: 29921610.
      View in: PubMed
    10. Kuchling J, Backner Y, Oertel FC, Raz N, Bellmann-Strobl J, Ruprecht K, Paul F, Levin N, Brandt AU, Scheel M. Comparison of probabilistic tractography and tract-based spatial statistics for assessing optic radiation damage in patients with autoimmune inflammatory disorders of the central nervous system. Neuroimage Clin. 2018; 19:538-550. PMID: 29984162.
      View in: PubMed
    11. Finke C, Zimmermann H, Pache F, Oertel FC, Chavarro VS, Kramarenko Y, Bellmann-Strobl J, Ruprecht K, Brandt AU, Paul F. Association of Visual Impairment in Neuromyelitis Optica Spectrum Disorder With Visual Network Reorganization. JAMA Neurol. 2018 03 01; 75(3):296-303. PMID: 29297041.
      View in: PubMed
    12. Oertel FC, Bosello F, Petzold A. Retinal optical coherence tomography shows optic disc changes in low intracranial pressure headaches: a case report. Acta Neurol Belg. 2018 Mar; 118(1):131-133. PMID: 29299774.
      View in: PubMed
    13. Oertel FC, Zimmermann H, Paul F, Brandt AU. Optical coherence tomography in neuromyelitis optica spectrum disorders: potential advantages for individualized monitoring of progression and therapy. EPMA J. 2018 Mar; 9(1):21-33. PMID: 29515685.
      View in: PubMed
    14. Oertel FC, Zimmermann H, Brandt AU, Paul F. [Optical coherence tomography in neuromyelitis optica spectrum disorders]. Nervenarzt. 2017 Dec; 88(12):1411-1420. PMID: 29119196.
      View in: PubMed
    15. Yadav SK, Motamedi S, Oberwahrenbrock T, Oertel FC, Polthier K, Paul F, Kadas EM, Brandt AU. CuBe: parametric modeling of 3D foveal shape using cubic Bézier. Biomed Opt Express. 2017 Sep 01; 8(9):4181-4199. PMID: 28966857.
      View in: PubMed
    16. Oertel FC, Zimmermann H, Mikolajczak J, Weinhold M, Kadas EM, Oberwahrenbrock T, Pache F, Bellmann-Strobl J, Ruprecht K, Paul F, Brandt AU. Contribution of blood vessels to retinal nerve fiber layer thickness in NMOSD. Neurol Neuroimmunol Neuroinflamm. 2017 May; 4(3):e338. PMID: 28451626.
      View in: PubMed
    17. Oertel FC, Kuchling J, Zimmermann H, Chien C, Schmidt F, Knier B, Bellmann-Strobl J, Korn T, Scheel M, Klistorner A, Ruprecht K, Paul F, Brandt AU. Microstructural visual system changes in AQP4-antibody-seropositive NMOSD. Neurol Neuroimmunol Neuroinflamm. 2017 May; 4(3):e334. PMID: 28255575.
      View in: PubMed
    18. Schmidt F, Zimmermann H, Mikolajczak J, Oertel FC, Pache F, Weinhold M, Schinzel J, Bellmann-Strobl J, Ruprecht K, Paul F, Brandt AU. Severe structural and functional visual system damage leads to profound loss of vision-related quality of life in patients with neuromyelitis optica spectrum disorders. Mult Scler Relat Disord. 2017 Jan; 11:45-50. PMID: 28104256.
      View in: PubMed
    19. Pache F, Zimmermann H, Mikolajczak J, Schumacher S, Lacheta A, Oertel FC, Bellmann-Strobl J, Jarius S, Wildemann B, Reindl M, Waldman A, Soelberg K, Asgari N, Ringelstein M, Aktas O, Gross N, Buttmann M, Ach T, Ruprecht K, Paul F, Brandt AU. MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 4: Afferent visual system damage after optic neuritis in MOG-IgG-seropositive versus AQP4-IgG-seropositive patients. J Neuroinflammation. 2016 11 01; 13(1):282. PMID: 27802824.
      View in: PubMed